newsfilter
← Latest News
Business Wire·

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update

Company accelerated enrollment in global multisite pilot study and significantly reduced operating expenses while refocusing resources to clinical and regulatory deliverables ENDRA Life Sciences Inc. (NASDAQ:NDRA), a